In a previous issue of Urology Times, this column discussed multiple procedures and the bundling edits for a single physician ("When to bill and not to bill for multiple procedures," May 2002, page 62). This article will address multiple procedures performed at the same encounter by two separate physicians.
Jessica Feehan, NP-C, discusses the expanding role of APPs in urology, from clinical leadership and procedures to care coordination and treatment initiation.
Jonathan E. Rosenberg, MD, discusses the FDA approval of perioperative durvalumab plus enfortumab vedotin and considerations for treatment selection in cisplatin-ineligible MIBC.
Sam S. Chang, MD, MBA, discusses treatment selection after BCG failure, including bladder-sparing options, cystectomy considerations, and the need for sequencing data.